Esperion Therapeutics
Amol Kheur has a diverse work experience spanning over two decades. Amol began their career at Schering-Plough Research Institute as an Apprentice in 1998, before moving on to FDC Limited as a Production Officer from 1999 to 2003. Amol then joined Apotex Inc. as a Technologist in 2004 and later worked at Patheon as a Scientist from 2005 to 2013. At Patheon, they also served as a Technical Project Leader from 2013 to 2017. Amol then returned to Apotex Inc. as a Scientific Leader, specializing in Technical Operations and Continuous Improvement, from 2017 to 2018. Currently, they hold the position of Associate Director, Chemistry and Manufacturing at Esperion - The Lipid Management Company, where they manage drug product development and manufacturing activities. With a strong background in research, formulation development, and process optimization, Amol has a well-rounded skill set in the pharmaceutical industry.
Amol Kheur's education history begins in 1980, where they attended SES High School Thane until 1992. During this time, they did not pursue a specific degree or field of study. In 1994, Amol enrolled at the University of Mumbai and completed a four-year B Pharmacy program, specializing in Pharmacy. Afterward, in 1999, they attended the National Institute of Labour Economics and Management, obtaining a Diploma in Production Management. Currently, there is no information available about any additional certifications or qualifications obtained by Amol Kheur.
This person is not in the org chart
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.